Close

Anika Therapeutics (ANIK) Tops Q1 EPS by 17c

Go back to Anika Therapeutics (ANIK) Tops Q1 EPS by 17c

Anika Reports First Quarter 2016 Financial Results

April 27, 2016 4:05 PM EDT

Total Revenue Increased 44% Year-over-Year

Commenced $25 million Accelerated Share Repurchase Program

BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary... More